FDA Inspection
Exelead, Inc.Exelead, Inc. – FDA Inspection, Dec 20, 2023
Record Details
This FDA Inspection record concerns Exelead, Inc., with an inspection on December 20, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f8900203-7a73-476a-a795-450d85e7698c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1225603
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Exelead, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 4, 2025 | Not classified | Detroit District Office | |
| July 30, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2018 | Not classified | Detroit District Office | |
| April 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 16, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Exelead, Inc.
- FDA Inspection 1287394 - 2025-09-04
- FDA Inspection 1062147 - 2018-07-30
- FDA Inspection 1055813 - 2018-05-15
- FDA Inspection 922118 - 2015-04-10
- FDA Inspection 878732 - 2014-05-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.